| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/15/2004 | EP1457210A1 Remedies and/or preventives for conformational diseases |
| 09/15/2004 | EP1457205A1 Angiogenesis inhibitor |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456411A2 Methods of detecting modification of genetic material |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456374A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456214A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456211A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456202A1 Benzothiazoles |
| 09/15/2004 | EP1456201A1 Benzhydryl derivatives |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456192A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds |
| 09/15/2004 | EP1456189A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 09/15/2004 | EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 09/15/2004 | EP1456187A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
| 09/15/2004 | EP1456184A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer |
| 09/15/2004 | EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 09/15/2004 | EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
| 09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
| 09/15/2004 | EP1456163A2 Improvements in pharmaceutical compositions |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455900A1 Methods of treating bacterial infections in dogs and cats |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455836A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455821A2 Parathyroid hormone antibodies and related methods |
| 09/15/2004 | EP1455808A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 09/15/2004 | EP1455795A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 09/15/2004 | EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 09/15/2004 | EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455783A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
| 09/15/2004 | EP1455780A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 09/15/2004 | EP1455779A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them |
| 09/15/2004 | EP1455770A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 09/15/2004 | EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455605A1 Soft drink replacer |
| 09/15/2004 | EP1455600A1 Food or pet food composition containing plant extract for bone health |
| 09/15/2004 | EP1370547B1 Benzoaxathiepin derivatives and their use as medicines |
| 09/15/2004 | EP1351709B1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 09/15/2004 | EP1339420B1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/15/2004 | EP1326862B1 Crystalline monohydrate of tiotropiumbromide, method for producing the same and the use thereof in the production of a medicament |
| 09/15/2004 | EP1322325A4 Inhibiting hepatitis c virus processing and replication |
| 09/15/2004 | EP1299395B1 Oxazinoquinolones useful for the treatment of viral infections |
| 09/15/2004 | EP1295878B1 Pyrazinone derivatives |
| 09/15/2004 | EP1294729B1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 09/15/2004 | EP1282425A4 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1133487B1 Antioxidants |
| 09/15/2004 | EP1133467B1 Ion channel modulating agents |
| 09/15/2004 | EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/15/2004 | EP1073467B1 Co-solvent formulations comprising a vitamin d compound |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | EP1043930A4 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 09/15/2004 | EP1001814B1 Controlled release microencapsulated ngf formulation |
| 09/15/2004 | EP1001774B1 Use of phospholamban inhibitors for increasing coronary flow |
| 09/15/2004 | EP0993460B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
| 09/15/2004 | EP0979104B1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 09/15/2004 | EP0941082B1 New use for 1,3-propanediol derivatives |
| 09/15/2004 | EP0889726B1 Novel cycloalkyl substituted imidazoles |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0841937B1 Use of betaglycan to reduce scarring |
| 09/15/2004 | EP0710109B1 Method for identifying a PDE IV inhibitor |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529751A Method for purifying enzyme, purified enzyme produced thereby and use of this enzyme |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529706A 哌嗪衍生物 Piperazine derivatives |
| 09/15/2004 | CN1529705A Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists |
| 09/15/2004 | CN1529703A 新的吲哚衍生物 The new indole derivatives |
| 09/15/2004 | CN1529699A Novel sulfonic acid derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529610A Remedies |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |